s6y

4 VALEANT PHARMACEUTICALS INTERNATIONAL: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001209500-09-000025

Documents

  1. PRIMARY DOCUMENT 4
  2. PRIMARY DOCUMENT 4
  3. EDGAR SUPPORTING DOCUMENT EX-24

On sec.gov